Active Coping: Interdisciplinary Program for Chronic Pain, Physiotherapy Unit (Spain)

Condition(s) studied

Investigational drug(s) / intervention(s)

Pain Neuroscience Education (PNE): Group sessions led by primary care physicians aimed at shifting participants' understanding of chronic pain mechanisms, reducing unhelpful beliefs about pain and movement, and promoting active coping strategies. Knowledge is assessed before and after sessions using a validated survey. Timing: March 2026

Healthy Habits and Psychological Intervention: Group sessions addressing nutrition and sleep hygiene, combined with group and individual psychological sessions focused on emotional wellbeing and coping tools for chronic pain management. Timing: April 2026

Therapeutic Exercise: Timing: May-June 2026 Description: Progressive group therapeutic exercise sessions led by physiotherapists, targeting physical function, balance, gait speed, and strength in participants with chronic back pain.

Study summary

The goal of this observational intervention study is to evaluate the impact of a multidisciplinary active coping program for chronic back pain in adults referred from Primary Care to the Physiotherapy Unit of Teruel Ensanche. The main questions it aims to answer are:

* Does the program improve physical function, measured through gait speed, balance, and chair stand tests?
* Does it reduce pain-related psychological factors such as kinesiophobia, catastrophizing, anxiety, and depression?
* Does it improve quality of life and sleep quality, and reduce analgesic medication use?

Participants will attend group sessions on pain neuroscience education, followed by sessions on healthy habits, nutrition and sleep hygiene and group psychological intervention focused on emotional wellbeing tools, and will complete therapeutic exercise sessions over the course of the program. They will also complete validated questionnaires and physical assessments at three timepoints: at baseline, at the end of the program, and at a 6-month follow-up.

Eligibility

Primary outcome measure(s)

• Change from Baseline in Health-Related Quality of Life as Measured by the SF-36 v2 at End of Program and 6-Month Follow-Up — Baseline, end of program, 6-month follow-up
  The SF-36 measures health-related quality of life across 8 dimensions: physical function, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Scores range from 0 to 100, where 0 indicates the worst possible health state and 100 indicates the best possible health state.

Trial sites (2)

More Universidad de Zaragoza trials in Spain

Other trials for the same condition